Huahui Health Ltd.

Boe Technology Group Co., Ltd.

National Institute of Biological Sciences, Beijing

Beijing Easpring Material Technology Co., Ltd.

Beijing Increase Innovative Drug Co., Ltd

Wenhui Li

Yang Liu

Dan Li

Jianhua Sui

Xiaochuan Chen

Haisheng Wang

Yingming Liu

Lei Zhang

Xiaoliang Ding

Ying Li

Jun Li

Bo Chen

Zhiqiang Wang

Jie Hu

Zhiyuan Zhang

Hongwu Zhang

Bo Peng

Yafei Liu

Huan Yan

Yanbin Chen

Fang Wang

Hanying Ruan

Xuequan Zhang

Xiangbing Qi

Zhiyun Kang

Feiteng Liu

Zhongmin Zhou

Fengfeng Mao

Chunmei Xue

Zhenzhen Wu

Baoxian Zhang

Yanwei Song

Anping Chen

Hengchun Ren

Provided are a Rho kinase inhibitor, a method for preparing same and the uses thereof. The Rho kinase inhibitor designates a compound of Formula I, a stereoisomer thereof or pharmaceutically acceptable salt thereof. The Rho kinase inhibitor promotes endothelial cells and endothelin expression, prostenin expression, and vascular factors NO synthesis and secretion, has a promoting effect on proprostin expression independently of the doses used, shows lower toxicity, while being safer.

Rho kinase inhibitor, method for preparing same and uses thereof

The present disclosure relates to the technical field of secondary battery, and discloses a positive electrode material and a preparation method and use therefor, a lithium-ion battery positive electrode poly piece, and a lithium-ion battery.

Positive electrode material and preparation method and use therefor, lithium-ion battery positive electrode pole piece, and lithium-ion battery

The invention provides for treating HBV or HDV infection or inhibiting human sodium taurocholate co-transporting polypeptide (hNTCP) with a polymeric bile acid or salt thereof, and pharmaceutical compositions comprising a polymeric bile acid or salt thereof, and a second HBV or HDV medicament.

Polymeric bile acid derivatives inhibit Hepatitis B and D virus and NTCP transport

Provided are human antibodies that specifically bind to HBV Pre-S1 domain ligand and inhibit HBV or HDV infection, antibodies binding to a set of amino acid residues that are critical for viral receptor engagement, and uses of these antibodies to prevent, or treat or diagnose HBV or HDV infection.

Anti-pre-S1 HBV antibodies

The invention provides cyclosporin A analogues that are NTCP inhibitors and useful for treating HBV and/or HDV infection(s), hepatoprotection and amelioration of hypercholesterolemia, diabetes and inhibiting cancer.

NTCP inhibitors

The present disclosure provides a sensor pixel, an ultrasonic sensor, an OLED display panel and an OLED display device, in which the sensor pixel includes a base substrate, a piezoelectric transducer and a sensor pixel circuit arranged on the base substrate; the energy sensor is connected to a first signal input terminal and the first node; the sensor pixel circuit includes a signal node control subcircuit for controlling the first node according to a signal of the reset signal terminal and a signal of the second signal input terminal, a drive subcircuit for providing a detection signal to the second node under the control of a signal of the first node, and a read subcircuit for providing a signal of the second node to the signal read line under the control of the read signal terminal.

Sensor pixel, ultrasonic sensor, OLED display panel, and OLED display device

Anti-Pre-S1 HBV antibodies

Growing community of inventors

Beijing, China

Wenhui Li